Although both nitric oxide (NO) and glutamate within the rostral ventrolateral medulla (RVLM) are important mediators of the central cardiovascular regulation, little is known about the functional interactions between these two mediators. Herein, we investigated the possible role of NO on the glutamatergic transmission of RVLM neurons. Whole-cell patch-clamp recordings were performed on visualized RVLM neurons in the brainstem slice preparation of rats. We found that bath application of Larginine, the substrate for NO production, significantly increased the amplitude of excitatory postsynaptic currents (EPSCs). This enhancement was completely abolished by coadministration of the NO synthase inhibitor 7-nitroindazole and mimicked by the NO donors 3-morpholinylsydnoneimine and spermine NONOate. Bath application of a NO-sensitive guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, or a protein kinase G (PKG) inhibitor, Rp-8-bromo-guanosine 3Ј,5Ј-cyclic monophosphorothioate, fully prevented the L-arginine-, 3-morpholinylsydnoneimine-, and N-[4-[1-(3-
-2-hydroxy-2-nitrosohydrazino]-butyl]-1,3-propanediamine (spermine NONOate)-induced synaptic potentiation. Direct activation of PKG with 8-(4-chlorophenylthio)-cGMP mimicked the action of NO donors. Furthermore, the augmentation by spermine NONOate of EPSC was accompanied by a reduction of the paired-pulse facilitation and synaptic failure rate of EPSCs. Spermine NONOate also significantly increased the frequency of both spontaneous and miniature EPSCs without altering their amplitude distribution. Pretreatment with the N-type Ca 2ϩ channel blocker -conotoxin GVIA selectively blocked the spermine NONOate-induced synaptic potentiation. These results suggest that NO acts presynaptically to elicit a synaptic potentiation on the RVLM neurons through an enhancement of presynaptic N-type Ca 2ϩ channel activity leading to facilitating glutamate release. The presynaptic action of NO is mediated by a cGMP/PKG-coupled signaling pathway.
It is well known that rostral ventrolateral medulla (RVLM) neurons play an important role in cardiovascular, respiratory, and nociceptive functions (Dampney, 1994) . Both electrophysiological and anatomical studies showed that a subset of RVLM neurons directly innervates preganglionic vasomotor neurons in the intermediolateral cell columns of the spinal cord, which are involved in the regulation of vasomotor and cardiac tone (Morrison et al., 1991; Deuchars et al., 1995) . In addition, the RVLM neurons are tonically active in vivo and receive convergent excitatory and inhibitory inputs from multiple sources (Mtui et al., 1995; Guyenet et al., 1996) . However, little is known regarding the physiological regulation of the tonic excitation of these neurons.
Nitric oxide (NO), an unstable diatomic radical synthesized from L-arginine by nitric-oxide synthase (NOS), is recognized as an important signaling molecule mediating a variety of physiological processes, including synaptic transmission and synaptic plasticity (Garthwaite, 1991) . In addition, considerable evidence suggests that NO is also involved in central cardiovascular regulation and that one of the potential sites in the central nervous system for NO to exert its modulation action on cardiovascular functions is the This work was supported in part by the Academic Excellence Program (grant 89-B-FA08-1-4 to K.S.H., S.H.H.C.) from the Ministry of Education, Taiwan.
RVLM (Hakim et al., 1995; Zanzinger et al., 1995; Hirooka et al., 1996; Kagiyama et al., 1997; . Studies using immunohistochemistry, NADPH-diaphorase staining, or autoradiography further demonstrate the presence of neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS in the RVLM (Vincent and Kimura, 1992; Chang et al., 2001) . We demonstrated recently ) that both nNOS and iNOS in the RVLM are tonically active under physiological conditions at the levels of functional expression and molecular synthesis. More importantly, we showed that the prevalence of nNOS over iNOS activity at the RVLM and the associated dominance of sympathoexcitation over sympathoinhibition underlie the maintenance of sympathetic vasomotor outflow and stable arterial pressure by the endogenous NO.
An important corollary to these findings is how NO exerts its modulatory action on RVLM neurons to regulate the cardiovascular function. Because glutamate is the major neurotransmitter in tonic excitatory drive of RVLM neurons (Sved et al., 2001) , we have therefore examined the role of NO on the glutamatergic transmission of RVLM neurons in brainstem slice preparations from immature rats using whole-cell patch-clamp recordings. Our results suggest that NO acts presynaptically to elicit a stable potentiation of synaptic transmission by means of a mechanism involving the NOsensitive sGC/cGMP/PKG-coupled signaling cascade, and these effects may have resulted in a sympathoexcitatory effect of NO in the RVLM.
Materials and Methods
Slice Preparation. Animal care was consistent with the guidelines set by the Laboratory Animal Center of National Cheng Kung University. All experimental procedures were approved by the NCKU Institutional Animal Use and Care Committee. Coronal brainstem slices containing RVLM were prepared from immature (7-to 9-day-old) male Sprague-Dawley rats for whole-cell patch-clamp recordings by procedures described previously (Hwang and Dun, 1998) . In brief, rats were killed by decapitation under halothane anesthesia, and coronal brainstem slices (200 m thick) were prepared using a vibrating microtome (Leica VT1000S; Leica, Nussloch, Germany). The slices were placed in a storage chamber of artificial cerebrospinal fluid (ACSF) oxygenated with 95% O 2 /5% CO 2 and kept at room temperature for at least 1 h before recording. The composition of the ACSF solution was 117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , and 11 mM glucose at pH 7.3 to 7.4 and equilibrated with 95% O 2 /5% CO 2 .
Patch-Clamp Recordings. For patch-clamp recording, slices were transferred to a recording chamber and fixed at the glass bottom of the chamber with a nylon grid on a platinum frame. The chamber consisted of a circular well of a low volume (1-2 ml) and was perfused constantly at room temperature (24-26°C) at a speed of 2 to 3 ml/min. Visualized whole-cell patch-clamp recordings of synaptically evoked EPSCs and spontaneous EPSCs (sEPSCs) were conducted using standard methods . The RVLM was recognized in the slice as an area ventral to the nucleus ambiguous that appears as a slightly dark area in a freshly prepared medullary slice and lateral to the paragigantocellular nucleus at a level rostral to the area postrema (Hwang and Dun, 1998) . The RVLM neurons were visualized throughout the experiment with an upright microscope (BX50WI; Olympus, Tokyo, Japan) equipped with a waterimmersion 40ϫ objective using Nomarski-type differential interference contrast optics combined with infrared videomicroscopy. Patch pipettes were pulled from borosilicate capillary tubing and heat polished. The electrode resistance was typically 4 to 5 M⍀. The composition of intracellular solution was 115 mM K-gluconate, 20 mM KCl, 10 mM HEPES, 2 mM MgCl 2 , 10 mM EGTA, 3 mM Na 2 ATP, 0.3 mM Na 3 GTP, 5 mM QX-314, and sucrose to bring osmolarity to 290 to 295 mOsM and pH to 7.3. After a high resistance seal (Ͼ 2 G⍀ before breaking into whole-cell mode) was obtained, suction was applied lightly through the pipette to break through the membrane. The cell was then maintained at Ϫ70 mV for several minutes to allow diffusion of the internal solution into the cell body and dendrites. Recordings were made using an Axopatch 200B (Axon Instruments, Union City, CA) amplifier. Electrical signals were lowpass filtered at 2 kHz and digitized at 4 to 10 kHz using a Digidata 1200B interface. An Intel Pentium-based computer with pCLAMP software (version 8.0; Axon Instruments) was used for on-line acquisition and off-line analysis of the data. For measurement of synaptically evoked EPSCs, a bipolar stainless steel stimulating electrode was applied to a site 300 to 450 m dorsal to the recorded neurons; the superfusate routinely contained bicuculline methiodide (10 M) and strychnine hydrochloride (0.5 M) to block inhibitory synaptic responses. The strength of synaptic transmission was quantified by measuring the amplitude of EPSCs over a 0.5-to 2-ms window concentrated around the peak. Series resistance (Rs) was calculated according to Rs ϭ 10 mV/I, where I was the peak of transient current (filtered with 10 kHz) evoked by the 10-mV testing pulse when the pipette capacitance was compensated fully. Only cells demonstrating Ͻ25 M⍀ series resistance (usually 10-20 M⍀) were used in these experiments.
sEPSCs comprise both action potential-dependent and -independent synaptic events observed in the absence of synaptic stimulation. In the present study, sEPSCs were recorded from RVLM neurons held in voltage clamp at a potential of Ϫ70 mV in the presence of bicuculline methiodide (10 M) and strychnine hydrochloride (0.5 M) and analyzed off-line using a commercially available software (Mini Analysis 4.3; Synaptosoft, Leonia, NJ). The software detects events based on amplitudes exceeding a threshold set just above the baseline noise of the recording. The threshold for detection was set at Ϫ3 pA. All detected events were re-examined and accepted or rejected based on subjective visual examination. The program then measured amplitudes and intervals between successive detected events. Frequencies were calculated by dividing the total number of detected events by the total time sampled. Periods of 5 to 10 min were analyzed for each pharmacological treatment, and these recordings were visually inspected to allow for the removal of artifacts. Cumulative probability plots were constructed to compare drug effects on the distribution of amplitude and interevent intervals from sEPSCs. Amplitude histograms were binned in 1-pA intervals.
Drug Application. All drugs were applied by dissolving them to the desired final concentrations in the ACSF and by switching the perfusion from control ACSF to drug-containing ACSF. Appropriate stock solutions of drugs were made and diluted with ACSF just before application. 7-NI, nimodipine, and ODQ were dissolved in dimethyl sulfoxide stock solutions and stored at Ϫ20°C until the day of experiment. Other drugs used in this study were dissolved in distilled water. The concentration of DMSO in the perfusion medium was 0.1%, which alone had no effect on the basal synaptic transmission. L-Arginine, 7-NI, ODQ, SIN-1, nimodipine, -conotoxin GVIA, 6-cyano-7-notroquinoxaline-2,3-dione (CNQX), spermine NONOate, D-(Ϫ)-␣-amino-5-phosphonopentanoic acid (D-APV), and bicuculline methiodide were purchased from Tocris Cookson (Bristol, UK); Darginine, strychnine hydrochloride, and tetrodotoxin (TTX) were obtained from Sigma (St. Louis, MO); Rp-8-Br-cGMPS and 8-pCPTcGMP were purchased from Calbiochem (La Jolla, CA). lated by paired or unpaired Student's t test. Probability values (p) of less than 0.05 were considered to represent significant differences. Comparisons between control and experimental distributions of sEPSC amplitude and interevent intervals were made by performing Kolmogorov-Smirnov test. Distributions were considered different using a conservative critical probability level of p Ͻ 0.01.
Results
Whole-cell patch-clamp recordings were made from neurons in the RVLM area. The RVLM was recognized in the slice as an area ventral to the compact region of nucleus ambiguous, which appeared as a slightly dark area in the freshly prepared slice, lateral to the paragigantocellular nucleus at the level rostral to area postrema, as shown in Fig.  1A . Other than the general location, RVLM neurons were not further characterized with respect to their transmitter phenotype or functional identity. All RVLM neurons included in this study had a longitudinal diameter of the soma ranging from 12 to 16 m, and their perikarya were rhombic, fusiform, or triangular in shape (Fig. 1B) . These neurons had a mean resting membrane potential, spike height, and input resistance of Ϫ61.2 Ϯ 2.8 mV, 72.3 Ϯ 2.9 mV, and 632 Ϯ 68 M⍀ (n ϭ 32), respectively, which are comparable with the values reported previously (Hwang and Dun, 1998) . In all experiments, neurons were clamped at Ϫ70 mV and EPSCs were evoked by intra-RVLM stimulation with bipolar stimulating electrode every 20 s in the presence of the GABA A receptor antagonist bicuculline methiodide (10 M) and the glycine receptor antagonist strychnine hydrochloride (0.5 M).
Exogenous NO-Induced Synaptic Potentiation. We examined initially the effect of L-arginine, the substrate for NO production by NOS, on the evoked EPSCs. In six of eight cells tested, bath application of 200 M L-arginine for 10 min produced a significant enhancement of evoked EPSCs. The mean EPSC amplitude after L-arginine was increased by 24.9 Ϯ 5.8% of the control baseline (n ϭ 8; p Ͻ 0.05; paired Student's t test) (Fig. 2 , A and C). The EPSCs recovered toward the control level within a few minutes after washout of L-arginine, suggesting the reversibility of L-arginine effect. At the end of each experiment, the non-NMDA receptor antagonist CNQX (20 M) and NMDA receptor antagonist D-APV (50 M) were added to the bath to ensure that the synaptic response was glutamatergic EPSC. In the same concentration, D-arginine did not cause a significant change of EPSCs (4.5 Ϯ 2.3% of the control baseline, n ϭ 4; p Ͼ 0.05; paired Student's t test) (Fig. 2C) .
To confirm that L-arginine-induced synaptic potentiation is caused by the synthesis of NO, we tested the effects of blocking nNOS. As shown in Fig. 2 , B and C, the increase in the amplitude of EPSCs by L-arginine (200 M) was completely prevented when 7-NI (100 M), a selective nNOS inhibitor, was preperfused for more than 10 min before L-arginine application (n ϭ 7; p Ͻ 0.05; unpaired Student's t test). In the presence of 7-NI, L-arginine increased the amplitude of EPSCs by a mean of 3.1 Ϯ 1.7% of pre-L-arginine level. Additionally, bath application of 7-NI (100 M) alone had a slight but not significant increase in the amplitude of EPSCs (7.5 Ϯ 3.8% of the control baseline, n ϭ 7; p Ͼ 0.05; paired Student's t test). These results suggest that the facilitating action of L-arginine on glutamatergic transmission on the RVLM neurons is mediated by the nNOS-mediated synthesis of NO.
Additional evidence that NO can induce a synaptic potentiation of glutamatergic transmission on the RVLM neurons came from experiments using the NO donors SIN-1 and spermine NONOate. Similar to L-arginine, bath application for 10 min of the SIN-1 (200 M) or spermine NONOate (100 M) produced a significant enhancement in six of eight and six of eight cells tested, respectively. The mean EPSC amplitude after SIN-1 or spermine NONOate was 24.9 Ϯ 4.4 and 22.5 Ϯ 4.3% of the control baseline, respectively (n ϭ 8 and 8; p Ͻ 0.05; paired Student's t test) (Fig. 3) .
NO Enhances Synaptic Transmission through a sGC/ cGMP/PKG-Coupled Signaling Pathway. An established signal transduction pathway for NO is activation of sGC, leading to an increase in intracellular cGMP levels (Ignarro, 1991) . Thus, to address the involvement of cGMP in the action of NO on glutamatergic transmission on the RVLM neurons, we investigated whether the pharmacological inhibition of sGC was able to prevent the synaptic potentiation caused by L-arginine and NO donors. Preincubation of the 
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at ASPET Journals on June 25, 2017 molpharm.aspetjournals.org slices with 10 M ODQ, a selective inhibitor of sGC, caused no change in the amplitude of EPSCs (107.6 Ϯ 4.6% of the control baseline; n ϭ 15; p Ͼ 0.05; paired Student's t test) but fully blocked the synaptic potentiation caused by L-arginine, SIN-1, and spermine NONOate (Fig. 4) . In the presence of ODQ (10 M), bath application of L-arginine (200 M), SIN-1 (200 M), or spermine NONOate (100 M) for 10 min produced only a minor increase in the amplitude of EPSCs by 12.5 Ϯ 3.2% (n ϭ 5), 9.5 Ϯ 3.6% (n ϭ 5), and 5.3 Ϯ 3.5% (n ϭ 5), respectively, which were significantly different from those produced by L-arginine, SIN-1, or spermine NONOate alone (p Ͻ 0.05; unpaired Student's t test).
Intracellular elevation of cGMP levels may result in the stimulation of PKG, which in turn modulates the function of a series of cellular substrates by increasing their phosphorylation state. To examine the role of PKG in the action of NO on glutamatergic transmission on the RVLM neurons, the effect of a selective PKG inhibitor, Rp-8-Br-cGMPS, on SIN-1-and spermine NONOate-induced synaptic potentiation was investigated. In these experiments, slices were incubated for at least 1 h in 50 M Rp-8-Br-cGMPS before being transferred to the recording chamber, where the concentration was maintained at 10 M. Pretreatment of the slices with Rp-8-Br-cGMPS completely blocked the SIN-1-and spermine NONOate-induced synaptic potentiation (Fig.  5, A and B) . In the presence of Rp-8-Br-cGMPS, bath application of SIN-1 (200 M) or spermine NONOate (100 M) for 10 min produced only a minor increase in the EPSC amplitude by a mean of 6.5 Ϯ 3.7 (n ϭ 5) and 10.3 Ϯ 5.9 (n ϭ 5), respectively, which were significantly different from those produced by SIN-1 or spermine NONOate alone (p Ͻ 0.05; unpaired Student's t test). To further examine the role of cGMP in synaptic potentiation on the RVLM neurons, we examined the effect of a membrane-permeable cGMP analog, 8-pCPT-cGMP. As shown in Fig. 5C , in six of seven cells tested, bath application of 8-pCPT-cGMP (50 M) for 20 min mimicked the facilitating action of L-arginine and NO donors. The mean EPSC amplitude after 8-pCPT-cGMP was increased by 24.5 Ϯ 4.3% of the control baseline (n ϭ 7; p Ͻ 0.05; paired Student's t test). These results suggest that NO-induced synaptic potentiation via a mechanism that is triggered by the activation of the sGC/cGMP/PKG-coupled signaling cascade.
Presynaptic Expression of Spermine NONOate-Induced Synaptic Potentiation. Because SIN-1 is now known to have other effects related to its ability to produce peroxynitrite, we therefore used only spermine NONOate to investigate the further mechanisms underlying the NO-induced synaptic potentiation on the RVLM neurons (Holm et al., 1998; Trackey et al., 2001) . To identify whether the NO action was on presynaptic or postsynaptic sites, two different approaches were used. We initially addressed this issue by examining the effect of spermine NONOate on the failure rate of single-fiber EPSCs evoked by minimal stimulation, which reflects changes in the presynaptic transmitter release (Stevens and Wang, 1994; Raastad, 1995) . As a typical example shown in Fig. 6A , the expression of spermine NONOate-induced synaptic potentiation is accompanied by a decrease in the synaptic failure rate. On average, the failure rate was decreased from 62.4 Ϯ 3.4% to 34.2 Ϯ 2.6% after spermine NONOate (100 M) application (n ϭ 5; p Ͻ 0.05; paired Student's t test) (Fig. 6B) .
To further test the possibility that spermine NONOateinduced synaptic potentiation through a presynaptic mechanism, we conducted studies examining the effects of spermine NONOate on PPF. When the excitatory afferents to the central neurons are activated twice with a short interval between each stimulus, the response to the second stimulus is generally facilitated in relation to the initial stimulus. This phenomenon is called a PPF and is attributed to an increase the amount of transmitter release to the second stimulus (Zucker, 1989) . On the other hand, the manipulations of presynaptic transmitter release may result in the change in the magnitude of PPF. If the spermine NONOate-induced synaptic potentiation involved a presynaptic mechanism of action, it will be associated with a change in the magnitude of PPF. Alternatively, if spermine NONOate induced synaptic modulation by another type of mechanism (e.g., reducing the sensitivity of postsynaptic receptors), then the PPF magnitude should be relatively unaffected. To test this hypothesis, the magnitude of PPF was determined at control before the application of spermine NONOate and 10 min after starting the application of spermine NONOate. Figure 6C shows a typical example of EPSCs synaptically evoked in response to a pair of stimuli with an interpulse interval of 30 ms. We found that the increase of the amplitude of EPSCs induced by spermine NONOate (100 M) was accompanied by a decrease in the magnitude of PPF. The magnitude of PPF was 2.29 Ϯ 0.18% before and 1.67 Ϯ 0.11% (n ϭ 5; p Ͻ 0.05; paired Student's t test) during the application of spermine NONOate. These results suggest that NO may act presynaptic site to modulate the transmitter release mechanisms in the RVLM.
Effects of NO on Spontaneous Excitatory Postsynaptic Currents. To further confirm the possibility that NO modulates the evoked EPSCs through a presynaptic mechanism, we examined the effects of spermine NONOate on sEPSCs. sEPSCs in the RVLM neurons were measured under voltage clamp at Ϫ70 mV and were pharmacologically isolated from spontaneous inhibitory currents by the inclusion of 10 M bicuculline methiodide and 0.5 M strychnine hydrochloride in the ACSF perfusing the slices. The sEPSCs were totally blocked by bath coapplication of CNQX (20 M) Fig. 6 . Failure and PPF analysis of spermine NONOate-induced synaptic potentiation. A, plot of EPSC amplitude recorded at Ϫ70 mV holding potential against time, before and after bath application of spermine NONOate (100 M) for 10 min, evoked at 0.1 Hz by minimal stimulation. It is clear that spermine NONOate produced a significant decrease in the number of failures. Sample traces are averages of six consecutive EPSCs recorded at the times indicated by the numbers on the graph. Calibration: 100 pA, 20 ms. B, summary of five experiments comparing the failure rate before and after spermine NONOate application. Superimposed EPSC traces from a representative experiment show baseline transmission (Control) and the decrease in failure rate after application of spermine NONOate. C, effects of spermine NONOate (100 M) on the PPF ratio calculated from the responses to paired-pulse stimulation with an interpulse interval of 30 ms. PPF ratio was defined as (p2/p1) ϫ 100%, where p1 and p2 are the amplitude of the EPSCs evoked by the first and second pulses, respectively. C, top, sample traces showing PPF before and after application of spermine NONOate. C, bottom, summary of experiments (n ϭ 5) showing that spermine NONOate (100 M)-induced synaptic potentiation was accompanied by a decrease in the magnitude of PPF ratio. and D-APV (50 M), confirming them to be true glutamate receptor-mediated events. Under control conditions, sEPSCs had a mean amplitude of 6.92 Ϯ 0.33 pA and a variable frequency ranging from 1.0 to 1.6 Hz (mean, 1.32 Ϯ 0.12 Hz; n ϭ 5). In five cells tested, spermine NONOate (100 M) markedly increased the mean frequency of the sEPSCs from 1.32 Ϯ 0.12 to 2.53 Ϯ 0.28 Hz (p Ͻ 0.05; paired Student's t test) (Fig. 7, A and E ). Significant differences in cumulative interevent interval distributions were observed in all five cells tested during spermine NONOate application; i.e., spermine NONOate shifted the interevent interval distribution of sEPSCs to shorter intervals (p Ͻ 0.001; KolmogorovSmirnov test). A typical example of recorded cell is shown in Fig. 7C . However, there was no significant effect of spermine NONOate (100 M) on the sEPSC amplitude. This can be observed by a lack of effect of spermine NONOate on either the amplitude histogram (Fig. 7B) or the cumulative probability plots (Fig. 7B, inset ; p ϭ 0.54; Kolmogorov-Smirnov test). The mean amplitude of sEPSCs recorded in the presence of spermine NONOate (100 M) was 8.08 Ϯ 0.56 pA, which was of comparable amplitude with that of sEPSCs recorded under control conditions (6.92 Ϯ 0.33 pA; p Ͼ 0.05; paired Student's t test).
The spontaneous synaptic events recorded from the RVLM neurons could be roughly divided into two components: TTXsensitive, action potential-dependent sEPSCs and TTX-resistant, action potential-independent miniature EPSCs (mEPSCs). The action potential-dependent sEPSCs arise from presynaptic impulses, whereas the action potential-independent mEPSCs are thought to result from spontaneous fusion of neurotransmitter-containing vesicles to the presynaptic terminal membrane in a manner independent of the activation of presynaptic voltage-dependent ion channels. We next examined the effect of spermine NONOate on mEPSCs to determine whether NO can modulate action potential-independent spontaneous events. TTX (1 M) was added to the perfusate in the presence of bicuculline methiodide and strychnine hydrochloride to eliminate sEPSCs arising from presynaptic impulses. In all cells recorded, the efficacy of TTX block of Na ϩ channels was monitored by observing the disappearance of the evoked EPSCs during maximal electrical stimulation (data not shown). Application of TTX (1 M) Fig. 7 . Effects of spermine NONOate on the glutamatergic sEPSCs. A, sample traces (five traces superimposed) of sEPSCs before and after application of 100 M spermine NONOate. Lower traces are the averaged sEPSCs of 30 events each before and after spermine NONOate (100 M) application with increasing time resolution, demonstrating the lack of effect on the amplitude and kinetics of sEPSCs. B, amplitude histograms of sEPSCs. The threshold for peak detection was set at Ϫ3 pA. Data were binned in 1-pA intervals. Inset, cumulative probability plots of sEPSCs before (solid line) and during (dash line) application of spermine NONOate (p ϭ 0.54; Kolmogorov-Smirnov test). C, cumulative interevent interval distribution illustrating a significant decrease in the interevent interval (i.e., increased frequency; p Ͻ 0.001; Kolmogorov-Smirnov test) during spermine NONOate application. D, summary of the effect of 100 M spermine NONOate on the average amplitude and frequency of sEPSCs (n ϭ 5). Data are presented as means Ϯ S.E.M. *, p Ͻ 0.05 compared with the control baseline; Student's unpaired t test. The data shown in A, B, and C were taken from the same cell. Holding potential, Ϫ70 mV.
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at ASPET Journals on June 25, 2017 molpharm.aspetjournals.org alone reduced both the amplitude and frequency of sEPSCs. Amplitude histograms show that TTX caused a reduction in the relative frequency of large-amplitude synaptic events. Additionally, TTX also reduce the relative frequency of largeamplitude synaptic events compared with control base (data not shown). Figure 8 illustrates that application of spermine NONOate (100 M) also led to a significant increase in the frequency of mEPSCs. In five cells tested, spermine NONOate (100 M) markedly increased the mean frequency of the sEPSCs from 0.62 Ϯ 0.14 to 1.08 Ϯ 0.15 Hz (p Ͻ 0.05; paired Student's t test) (Fig. 8, A and E ). Significant differences in cumulative interevent interval distributions were observed in all five cells tested during spermine NONOate application; i.e., spermine NONOate shifted the interevent interval distribution of mEPSCs to shorter intervals (p Ͻ 0.01; Kolmogorov-Smirnov test). A typical example of recorded cell is shown in Fig. 8C . However, there was no significant effect of spermine NONOate (100 M) on the mEPSC amplitude. This can be observed by a lack of effect of spermine NONOate on either the amplitude histogram (Fig. 8B) or the cumulative probability plots (Fig. 8B, inset ; p ϭ 0.94; Kolmogorov-Smirnov test). The mean amplitude of mEPSCs recorded in the presence of spermine NONOate (100 M) was 6.63 Ϯ 0.35 pA, which was of an amplitude comparable with that of mEPSCs recorded under control condition (6.19 Ϯ 0.28 pA; p Ͼ 0.05; paired Student's t test). Therefore, these data further suggest that NO may act presynaptically to enhance the amount of glutamate release without changing the postsynaptic sensitivity to glutamate.
N-Type Ca 2؉ Channels Contribute to the Spermine NONOate-Induced Synaptic Potentiation. In a final series of experiments, we examined the possibility that NO modulates evoked EPSCs through an action on presynaptic voltage-sensitive Ca 2ϩ channels, which contribute to supporting glutamate release. If spermine NONOate acts on presynaptic Ca 2ϩ channels to affect glutamate release mechanisms, it would do so through one or more channel subtypes. We therefore examined the effect of spermine NONOate on the amplitude of EPSC before and after selective blockade of each of Ca 2ϩ channel subtypes. We first examined the possible contribution of N-type Ca 2ϩ channel enhancement to spermine NONOate-induced synaptic potentiation. A repre- Fig. 8 . Effects of spermine NONOate on the action potential-independent (TTX-resistant) mEPSCs. A, sample traces (five traces superimposed) of mEPSCs before (baseline: in the presence of 1 M TTX to block Na ϩ channels) and after application of 100 M spermine NONOate. Lower traces are the averaged mEPSCs of 30 events each before and after spermine NONOate (100 M) application with increasing time resolution, demonstrating the lack of effect on the amplitude and kinetics of mEPSCs. B, amplitude histograms of mEPSCs. The threshold for peak detection was set at Ϫ3 pA. Data were binned in 1 pA intervals. Inset, cumulative probability plots of mEPSCs before (solid line) and during (dashed line) application of spermine NONOate (p ϭ 0.94; Kolmogorov-Smirnov test). C, cumulative interevent interval distribution illustrating a significant decrease in the interevent interval (i.e., increased frequency; p Ͻ 0.01; Kolmogorov-Smirnov test) during spermine NONOate application. D, summary of the effect of 100 M spermine NONOate on the average amplitude and frequency of mEPSCs (n ϭ 5). Data are presented as means Ϯ S.E.M. *, p Ͻ 0.05 compared with the control baseline; Student's unpaired t test. The data shown in A, B, and C were taken from the same cell. Holding potential, Ϫ70 mV. sentative cell recorded under this condition is shown in Fig.  9A . Application of -conotoxin-GVIA 1 M, a concentration that should selectively block N-type Ca 2ϩ channels (Kasai et al., 1987) , caused a rapid, robust, and irreversible suppression of the amplitude of EPSCs by 72% and completely blocked the spermine NONOate action. In six neurons tested, spermine NONOate (100 M) produced a 5.2 Ϯ 3.6% increase in the amplitude of EPSCs after the application of -cono- toxin-GVIA, which was significantly different from that produced by spermine NONOate alone (22.5 Ϯ 4.3%, n ϭ 8; p Ͻ 0.05; unpaired Student's t test) (Fig. 9E) .
We next investigated the role of P/Q-type Ca 2ϩ channels in the modulation caused by spermine NONOate. -Aga-TK, a toxin purified from the venom of funnel web spider, was used in these experiments. -Aga-TK has been reported to selectively block the P-type Ca 2ϩ channel at nanomolar concentrations, whereas at concentration Ͼ100 nM, it blocks not only P-type but also Q-type Ca 2ϩ channels (Wheeler et al., 1994) . As a representative experiment shown in Fig. 9B , application of 200 nM -Aga-TK reduced the amplitude of EPSCs by 32% compared with baseline. After the application of -Aga-TK, bath application of spermine NONOate (100 M) for 10 min was still able to potentiate the residual EPSC amplitude by 21.8 Ϯ 5.2% compared with baseline (n ϭ 5), which was not significantly different from the synaptic potentiation produced by spermine NONOate alone (22.5 Ϯ 4.3%, n ϭ 8; p Ͼ 0.05; unpaired Student's t test) (Fig. 9E) .
We further examined the possible contribution of L-type Ca 2ϩ channel enhancement to spermine NONOate-induced synaptic potentiation. As a representative experiment shown in Fig. 9C , pretreatment of the slices with the selective Ltype Ca 2ϩ channel blocker nimodipine (20 M) affected neither the basal EPSC amplitude nor the spermine NONOateinduced synaptic potentiation. In five neurons tested, spermine NONOate (100 M) produced a 26.7 Ϯ 4.8% increase in the amplitude of EPSCs after the application of nimodipine, which was not significantly different from that produced by spermine NONOate alone (22.5 Ϯ 4.3%, n ϭ 8; p Ͼ 0.05; unpaired Student's t test) (Fig. 9E ). The conclusion from this series of experiments is that spermine NONOateinduced enhancement of glutamatergic synaptic transmission on the RVLM neurons is most likely through an increase the activity of presynaptic N-type but not P/Q-type or L-type Ca 2ϩ channel subtypes.
Discussion
The present study demonstrates for the first time that NO enhances glutamatergic transmission in immature rat RVLM neurons from brainstem slices. This action involves activation of sGC and an increase in intracellular levels of cGMP, followed by activation of PKG to modulate presynaptic N-type Ca 2ϩ channel activity. Concerning the locus of NO-induced synaptic potentiation, a presynaptic site of action seems to be involved. We can give three lines of evidence to support this conclusion. First, the NO donor spermine NONOate produces a significant decrease in the failure rate of single-fiber EPSCs evoked by minimal stimulation (Fig. 6, A and B) . Second, an increase in synaptic transmission by spermine NONOate was accompanied by a decrease in the magnitude of PPF ratio of synaptically evoked responses (Fig. 6C) , which is usually considered an indication of a presynaptic mode of drug actions (Zucker, 1989) . Third, and most importantly, spermine NONOate significantly increases the frequency of both sEPSCs and mEPSCs but did not affect their amplitude (Fig. 7 and 8) . A change in the amplitude of sEPSCs and mEPSCs is usually interpreted as a postsynaptic modification, whereas a change in their frequency is typically associated with mechanisms that increase the probability of nerve-evoked transmitter release (Katz, 1969) . Thus, the lack of effect of spermine NONOate on the amplitude of sEPSCs and mEPSCs also implies that the modulation of synaptic transmission by NO on the RVLM neurons is not mediated by a change in postsynaptic sensitivity to glutamate.
NO has been shown to activate several signal transduction pathways, including sGC, to increase cGMP levels (Garthwaite, 1991) . The involvement of NO/cGMP pathway in the modulation of glutamatergic transmission has been demonstrated in slice preparations from the hippocampus (O'Dell et al., 1991; Boulton et al., 1994) and locus ceruleus (Pineda et al., 1996) and in cultured hippocampal neurons (Arancio et al., 1995) . In the present results, both L-arginine and NO donor-induced synaptic potentiation were prevented by a selective NO-sensitive sGC inhibitor, ODQ (Fig. 4) . It is likely that NO is acting through a NO-sensitive sGC/cGMP signaling pathway to increase glutamatergic transmission on the RVLM neurons. Various potential mechanisms can account for the cellular function of cGMP in different systems. The specific targets for cGMP are PKG (Paupardin-Tritsch et al., 1986) , cyclic nucleotide-gated cationic channels (Fesenko et al., 1985) , and cyclic nucleotide-stimulated and -inhibited phosphodiesterases (Nicholson et al., 1991) . In the present study, experiments were performed with activator (8-pCPTcGMP) or inhibitor (Rp-8-Br-cGMPS) of PKG to characterize the pathway involved in NO effect. The experiments showed that preincubation of the slices with Rp-8-Br-cGMPS fully prevented SIN-1-and spermine NONOate-induced synaptic potentiation (Fig. 5, A and B) , whereas bath application of 8-pCPT-cGMP mimicked the action of NO donors (Fig. 5C ). In addition, both 8-pCPT-cGMP and Rp-8-Br-cGMPS have a negligible activity on cyclic nucleotide-stimulated and -inhibited phosphodiesterases, indicating that the activation of cyclic-nucleotide phosphodiesterases is not necessary for the NO-induced synaptic potentiation. Therefore, our results support the idea that NO-induced synaptic potentiation on the RVLM neurons is mediated via a cGMP/PKG-coupled signaling pathway. However, we could not exclude the possibility that the increase in cGMP levels by NO-stimulated sGC may directly modulate presynaptic cyclic nucleotidegated cationic channels, which leads to depolarization of the presynaptic terminals; potentiation of transmitter release may also play a part role in the NO-induced synaptic potentiation (Ludwig et al., 1998) .
What is the biological step downstream of cGMP/PKG responsible for the NO-induced synaptic potentiation? The most likely candidate is their facilitatory coupling with presynaptic voltage-sensitive Ca 2ϩ channels, which in turn enhances glutamate release. Various subtypes of voltage-sensitive Ca 2ϩ channels are known to be involved in neurotransmitter release. In the present study, by using the highly selective inhibitors of voltage-sensitive Ca 2ϩ channels, distinct subtypes of voltage-sensitive Ca 2ϩ channels contributing to the evoked release of glutamate on the RVLM neurons were identified. Data reported in this article represent the first experimental evidence that N-and P/Q-type Ca 2ϩ channels make the major contribution to the evoked glutamate release in the RVLM area (Fig. 9D) . The finding that spermine NONOate-induced synaptic potentiation dropped from 22 to 5% after exposure to the N-type Ca 2ϩ channel blocker -CgTX GVIA (Fig. 9, A and D) is evidence that the enhancement of this channel activity is the primary mechanism of NO-induced potentiation of glutamate release from presynaptic nerve terminals. In salamander retinal ganglion cells, a recent study also demonstrated that NO can enhance N-type Ca 2ϩ channel activity by facilitating their voltage-dependent activation via a mechanism involving sGC/cGMP/PKG-dependent phosphorylation (Hirooka et al., 2000) . The evidence that blockade of P/Q-type and L-type Ca 2ϩ channels had no effect on the spermine NONOateinduced synaptic potentiation seems to rule out the involvement of these channel subtypes.
Our observation that spermine NONOate also enhances the frequency but not the amplitude of the mEPSCs suggests that NO has effect in addition to its modulation of voltagesensitive Ca 2ϩ channels. Because concentrations of Ca 2ϩ channel blockers sufficient to abolish all evoked transmitter release have no effect on mEPSC frequency, changes in mEPSC frequency are not likely to be the result of changes in Ca 2ϩ influx from voltage-sensitive Ca 2ϩ channels at the resting membrane potentials (Scanziani et al., 1992) . The NOmediated increase in mEPSC frequency therefore may reflect a direct action on the exocytotic apparatus or protein kinasedependent phosphorylation of targets that regulate the vesicle release machinery.
An important issue that arose in this study was whether the NO concentrations released from donor compounds could be reached under physiological or pathological conditions in the brain. Although the local NO concentrations in slice preparations produced by SIN-1 (200 M) and spermine NONOate (100 M) remain unknown, it has been demonstrated that spermine NONOate at a concentration of 82.7 M will generate a peak NO concentration in the Tyrode's solution of 3 to 4 M (Ramamurthi and Lewis, 1997). Moreover, tissue-derived factors may accelerate NO breakdown in slice studies, because NO decays more quickly when perfused over tissues compared with the experiments in tubes (Palmer et al., 1987) . In a recent report, it was calculated that the concentrations of NO produced by another NO donor, 2,2-diethyl-1-nitroso-oxyhydrazine (100 -300 M), were in the 100 nM range in the hippocampal slices (Bon and Garthwaite, 2001 ). Hence, the local NO concentrations produced by 100 M spermine NONOate in the present study should be in the 50 to 100 nM range. Because it is known that the physiological range of NO concentration in the brain is 10 to 100 nM and ischemic conditions produce NO of about 2 to 4 M (Shibuki and Okada, 1991; Malinski and Taha, 1992) , the NO-induced synaptic potentiation on the RVLM neurons described in the present study would be expected to occur in vivo under physiological or ischemic situations.
In conclusion, we here extended the earlier studies on the role of NO and glutamate in the RVLM, providing further evidence that NO may substantially enhance glutamatergic transmission on the RVLM neurons. Consisting of premotor sympathetic neurons, the RVLM is believed to maintain basal levels of systemic arterial pressure (Ross et al., 1984) by providing tonic excitation to preganglionic sympathetic neurons in the intermediolateral cell column of the spinal cord. The glutamatergic afferents to the RVLM control the premotor neurons, which in turn excite the preganglionic neurons in the spinal cord, which send their axons to the periphery and synapses with sympathetic postganglionic neurons. Via the increase in the excitatory synaptic transmission in the RVLM, NO could indirectly excite preganglionic neurons of the spinal cord, increasing their firing rate, and trigger sympathoexcitatory functions, such as increasing SAP and heart rate.
